Abstract:3D cell printing is an emerging technology for fabricating complex cell-laden constructs with precise and pre-designed geometry, structure and composition to overcome the limitations of 2D cell culture and conventional tissue engineering scaffold technology. This technology enables spatial manipulation of cells and biomaterials, also referred to as 'bioink', and thus allows study of cellular interactions in a 3D microenvironment and/or in the formation of functional tissues and organs. Recently, many efforts have been made to develop new bioinks and to apply more cell sources for better biocompatibility and biofunctionality. However, the influences of printing parameters on the shape fidelity of 3D constructs as well as on cell viability after the cell printing process have been poorly characterized. Furthermore, parameter optimization based on a specific cell type might not be suitable for other types of cells, especially cells with high sensibility. In this study, we systematically studied the influence of bioink properties and printing parameters on bioink printability and embryonic stem cell (ESC) viability in the process of extrusion-based cell printing, also known as bioplotting. A novel method was established to determine suitable conditions for bioplotting ESCs to achieve both good printability and high cell viability. The rheological properties of gelatin/alginate bioinks were evaluated to determine the gelation properties under different bioink compositions, printing temperatures and holding times. The bioink printability was characterized by a newly developed semi-quantitative method. The results demonstrated that bioinks with longer gelation times would result in poorer printability. The live/dead assay showed that ESC viability increased with higher printing temperatures and lower gelatin concentrations. Furthermore, an exponential relationship was obtained between ESC viability and induced shear stress. By defining the proper printability and acceptable viability ranges, a combined parameters region was obtained. This study provides guidance for parameter optimization and the fine-tuning of 3D cell printing processes regarding both bioink printability and cell viability after bioplotting, especially for easily damaged cells, like ESCs.

Bioprinting of Stem Cells: Interplay of Bioprinting Process, Bioinks, and Stem Cell Properties.

Bioprinting of Stem Cells: Interplay of Bioprinting Process, Bioinks, and Stem Cell Properties

Bioprinting: a focus on improving bioink printability and cell performance based on different process parameters

3D Bioprinting: A Novel Avenue for Manufacturing Tissues and Organs

3D Bioprinting: an Emerging Technology Full of Opportunities and Challenges

Biodegradable Polymers and Stem Cells for Bioprinting.

Inkjet 3D Bioprinting for Tissue Engineering and Pharmaceutics

3D Bioprinting: from Structure to Function

Three-dimensional bioprinting in tissue engineering and regenerative medicine

Advances in 3D bioprinting for regenerative medicine applications

Techniques and applications of 3D bioprinting

3D Bioprinting: from Benches to Translational Applications.

Bioprintability: Physiomechanical and Biological Requirements of Materials for 3D Bioprinting Processes

Evaluation of Bioink Printability for Bioprinting Applications

Applications of 3D bioprinting in tissue engineering: advantages, deficiencies, improvements, and future perspectives.

Simultaneous Multimaterial Multimethod Bioprinting

3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances

Recent developments and challenges of 3D bioprinting technologies

Effect of bioink properties on printability and cell viability for 3D bioplotting of embryonic stem cells

Current Advances in 3D Bioprinting Technology and Its Applications for Tissue Engineering

Development of 3D bioprinting: From printing methods to biomedical applications